ERBB2 and cancer: According to the studies above, a novel series of 4,5-dihydro-1H-pyrazole derivatives containing thiourea skeleton and dioxin structure was designed as potential HER-2 selective inhibitors and predicted to have a positive progress with a sound cancer therapeutic benefit.